ApprovalTrail

Approval · Notice of Compliance 6676 · 1997

DECTOMAX INJECTABLE SOLUTION: Notice of Compliance 6676

Issued June 26, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6676
Date
June 26, 1997
Company
Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Additional species: swine
Therapeutic class
Antiparasitic

Products in this notice

BrandDINStatus today
DECTOMAX INJECTABLE SOLUTIONNot yet assigned—

Medicinal ingredients